Remedium Capital Partners, LLC — 13F Holdings

2026 Q3  ·  8 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Remedium Capital Partners, LLC maintained a portfolio of 8 distinct positions. The most significant new addition was Korsana Biosciences Inc, now representing 6.06% of the total fund value. They heavily accumulated shares in Damora Therapeutics Inc, increasing the position by 466.2%. Conversely, Remedium Capital Partners, LLC completely exited their position in Apogee Therapeutics Inc.
Position History hover any row below to update
Loading…
PCA Score Concentration Risk
Risk ENB
Total Positions
8
Quarter
2026 Q3
Top Holding
SYRE (37.8%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-8 of 8

Remedium Capital Partners, LLC Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
SYRE
Spyre Therapeut...
Healthcare 37.77% 28.78% #1 1
Prev: #2
6.0
—
-303,549 -20.7%
P
S
1,160,620 $103,329,999
$36.94 +169.0%
$89.03 +11.6%
2025 Q4 13F Filing 2026-09-30 2026-11-13
ORKA
Oruka Therapeut...
Healthcare 29.05% 32.99% #2 1
Prev: #1
5.5
—
-611,511 -39.1%
P
S
954,150 $79,471,154
$33.65 +194.9%
$83.29 +19.1%
2025 Q4 13F Filing 2026-09-30 2026-11-13
N/A
Damora Therapeu...
Unknown 15.91% — #3
Prev: #—
8.5
—
2,045,473 —
NEW
2,045,473 $43,527,665 — 13F Filing 2026-09-30 2026-11-13
JBIO
Jade Bioscience...
Healthcare 9.28% 7.76% #4 1
Prev: #5
6.2
—
230,064 14.6%
P
S
1,807,814 $25,399,787 2025 Q4 13F Filing 2026-09-30 2026-11-13
KRSA
Korsana Bioscie...
Healthcare 6.06% — #5
Prev: #—
6.4
—
518,500 —
NEW
518,500 $16,592,000 2026 Q3 13F Filing 2026-09-30 2026-11-13
N/A
Crescent Biopha...
Unknown 1.93% 1.44% #6
Prev: #6
1.8
—
no change no change
P
S
361,250 $5,270,638 — 13F Filing 2026-09-30 2026-11-13
GLTO
Damora Therapeu...
Healthcare 0.00% 11.78%
Sold All 😨
(Was: #4)
0.0
—
-2,045,473 -100.0%
CLOSED
— $— 2025 Q4 13F Filing 2026-09-30 2026-11-13
APGE
Apogee Therapeu...
Healthcare 0.00% 17.24%
Sold All 😨
(Was: #3)
0.0
—
-586,691 -100.0%
CLOSED
— $— 2025 Q4 13F Filing 2026-09-30 2026-11-13
Showing 1-8 of 8 holdings

Unlock Full Remedium Capital Partners, LLC Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →